Products

Flowers

Medicinal cannabis flowers sourced from certified cultivation facilities in Canada and Portugal. The portfolio includes a range of cannabinoid profiles and product formats developed to meet the requirements of healthcare professionals and patients.

Pastilles

Cannabinoid pastilles manufactured in Spain under GMP standards, offering a convenient oral dosage format within the Curaleaf product portfolio. Available in selected cannabinoid strengths and flavour profiles.

Vape

Curaleaf inhalation products have been developed for use with the QMID device platform, combining formulation and device technology within a single integrated system. Manufactured in Australia, these products form part of Curaleaf's next-generation cannabinoid delivery ecosystem.

Full Spectrum Extracts

Cannabis full spectrum extracts manufactured in Spain under GMP standards and available in a range of cannabinoid ratios and concentrations. Developed to provide healthcare professionals with flexible formulation options within the Curaleaf portfolio.


Understanding our vape formulations: dosing, titration and clinical evidence

Consistent dosing is central to safe medicinal cannabis prescribing. The following overview provides clinicians with the evidence base and titration framework underpinning our inhaled formulations and the QMID delivery platform.


Start prescribing inhaled medicinal cannabis

Access our step-by-step dosing and titration guide for inhaled medicinal cannabis formulations.

Back to top